Thoma Bravo to buy majority stake in MedeAnalytics

Thoma Bravo has agreed to acquire a majority stake in MedeAnalytics Inc, a provider of financial performance analytics for the healthcare market. No financial terms were disclosed. As a result of the transaction, MedeAnalytics' previous backers Bain Capital Integral Investors LLC and Emergence Capital Partners will retain their minority stakes.

DealsNorth AmericaUSBriefs